Comorbidity in cirrhosis

World Journal of Gastroenterology

Volumn 20, Issue 23, 2014, Pages 7223-7230

  Jepsen, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Comorbidity; Epidemiology; Liver cirrhosis; Prognosis

Indexed keywords

ACUTE PANCREATITIS; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DIABETES MELLITUS; EPILEPSY; GASTROINTESTINAL DISEASE; HUMAN; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MENTAL DISEASE; PREVALENCE; REVIEW; SCORING SYSTEM; SMOKING; SUBSTANCE ABUSE; SURGICAL RISK; VENOUS THROMBOEMBOLISM; HEALTH STATUS; HEALTH STATUS INDICATOR; MORTALITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

COMORBIDITY; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84902665807     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i23.7223     Document Type: Review

References (53)

1. Ording AG, Sørensen HT. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. Clin Epidemiol 2013; 5: 199-203 [PMID: 23861599 DOI: 10.2147/CLEP.S45305]
2. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970; 23: 455-468
3. Jepsen P, Vilstrup H, Lash TL. Development and validation of a comorbidity scoring system for patients with cirrhosis. Gastroenterology 2014; 146: 147-156; quiz e15-16 [PMID: 24055278 DOI: 10.1053/j.gastro.2013.09.019]
4. Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sørensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 2008; 48: 214-220 [PMID: 18537190 DOI: 10.1002/hep.22341]
5. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687 [PMID: 16929323 DOI: 10.1038/nrc1934]
6. Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007; 13: 1515-1520 [PMID: 17969207 DOI: 10.1002/lt.21172]
7. Grosso G, di Francesco F, Vizzini G, Mistretta A, Pagano D, Echeverri GJ, Spada M, Basile F, Gridelli B, Gruttadauria S. The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience. Transplant Proc 2012; 44: 1298-1302 [PMID: 22664004 DOI: 10.1016/j.tra nsproceed.2012.01.131]
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383 [PMID: 3558716]
9. Koek HL, Soedamah-Muthu SS, Kardaun JW, Gevers E, de Bruin A, Reitsma JB, Bots ML, Grobbee DE. Short-and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus. Eur J Epidemiol 2007; 22: 883-888 [PMID: 17926133 DOI: 10.1007/ s10654-007-9191-5]
10. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006; 101: 945-953 [PMID: 16573778 DOI: 10.1111/ j.1572-0241.2006.00518.x]
11. Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg 2010; 251: 51-58 [PMID: 20009753 DOI: 10.1097/SLA.0b013e3181b975b8]
12. Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sørensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012; 344: e356 [PMID: 22279115 DOI: 10.1136/bmj.e356]
13. Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ 2011; 343: d5364 [PMID: 21903695 DOI: 10.1136/bmj.d5364]
14. Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int 2012; 32: 79-84 [PMID: 21745279 DOI: 10.1111/j.1478-3231.2011.02517.x]
15. Jassal SV, Schaubel DE, Fenton SS. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 2005; 46: 136-142 [PMID: 15983967]
16. Wasilewicz M, Raszeja-Wyszomirska J, Wunsch E, Wójcicki M, Milkiewicz P. Modified Charlson Comorbidity Index in predicting early mortality after liver transplantation. Transplant Proc 2009; 41: 3117-3118 [PMID: 19857690 DOI: 10.1016/j.transproceed.2009.07.097]
17. Younossi ZM, Henry L, Stepanova M. A new comorbidity model for predicting mortality in patients with cirrhosis: does it work? Gastroenterology 2014; 146: 19-24 [PMID: 24287302 DOI: 10.1053/j.gastro.2013.11.026]
18. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231 [PMID: 16298014]
19. Wlazlo N, van Greevenbroek MM, Curvers J, Schoon EJ, Friederich P, Twisk JW, Bravenboer B, Stehouwer CD. Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality. Clin Sci (Lond) 2013; 125: 341-348 [PMID: 23566037 DOI: 10.1042/CS20120596]
20. Quintana JO, García-Compean D, González JA, Pérez JZ, González FJ, Espinosa LE, Hernández PL, Cabello ER, Villarreal ER, Rendón RF, Garza HM. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Ann Hepatol 2011; 10: 56-62 [PMID: 21301011]
21. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15: 280-288 [PMID: 19140227]
22. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-125 [PMID: 8020880]
23. Lee SS, Liu H. Cardiovascular determinants of survival in cirrhosis. Gut 2007; 56: 746-748 [PMID: 17519479 DOI: 10.1136/ gut.2006.112169]
24. Berzigotti A, Bonfiglioli A, Muscari A, Bianchi G, Libassi S, Bernardi M, Zoli M. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int 2005; 25: 331-336 [PMID: 15780058 DOI: 10.1111/j.1478-3231.2005.01002.x]
25. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 2011; 56: 2152-2159 [PMID: 21279685 DOI: 10.1007/ s10620-011-1582-5]
26. Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 2013; 11: 1064-1074 [PMID: 23506859 DOI: 10.1016/j.cgh.2013.02.026]
27. Boyer TD. The patient who cannot receive beta-blockers. In: Groszmann RJ, Bosch J, editors. Portal hypertension in the 21st century. 1st ed. Netherlands: Springer, 2004: 301-307
28. Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev 2012; 8: CD004544 [PMID: 22895942 DOI: 10.1002/14651858.CD004544.pub2]
29. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, Valla DC. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23: 45-53 [PMID: 12640727]
30. Altamirano J, Bataller R. Cigarette smoking and chronic liver diseases. Gut 2010; 59: 1159-1162 [PMID: 20650922 DOI: 10.1136/gut.2008.162453]
31. Aparisi L, Sabater L, Del-Olmo J, Sastre J, Serra MA, Campello R, Bautista D, Wassel A, Rodrigo JM. Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects? World J Gastroenterol 2008; 14: 6171-6179 [PMID: 18985807]
32. Nakamura Y, Kobayashi Y, Ishikawa A, Maruyama K, Higuchi S. Severe chronic pancreatitis and severe liver cirrhosis have different frequencies and are independent risk factors in male Japanese alcoholics. J Gastroenterol 2004; 39: 879-887 [PMID: 15565408 DOI: 10.1007/s00535-004-1405-y]
33. Nøjgaard C, Bendtsen F, Becker U, Andersen JR, Holst C, Matzen P. Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. Clin Gastroenterol Hepatol 2010; 8: 384-390 [PMID: 20036762 DOI: 10.1016/j.cgh.2009.12.016]
34. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology 2012; 56: 698-705 [PMID: 22378148 DOI: 10.1002/hep.25684]
35. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305 [PMID: 15385656 DOI: 10.1056/NEJMoa041031]
36. Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol 2012; 18: 3035-3049 [PMID: 22791939 DOI: 10.3748/wjg.v18.i24.3035]
37. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 702-709 [PMID: 21325171 DOI: 10.1136/gut.2010.236133]
38. Angeli P, Sanyal A, Moller S, Alessandria C, Gadano A, Kim R, Sarin SK, Bernardi M. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int 2013; 33: 16-23 [PMID: 22507181 DOI: 10.1111/ j.1478-3231.2012.02807.x]
39. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229 [PMID: 19519924 DOI: 10.1186/ar2669]
40. Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994; 344: 918-921 [PMID: 7934347]
41. Delanty N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001; 10: 116-119 [PMID: 11407954 DOI: 10.1053/seiz.2000.0482]
42. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010; 51: 1675-1682 [PMID: 20186844 DOI: 10.1002/hep.23500]
43. St Germaine-Smith C, Liu M, Quan H, Wiebe S, Jette N. Development of an epilepsy-specific risk adjustment comorbidity index. Epilepsia 2011; 52: 2161-2167 [PMID: 22004000 DOI: 10.1111/j.1528-1167.2011.03292.x]
44. Pilke A, Partinen M, Kovanen J. Status epilepticus and alcohol abuse: an analysis of 82 status epilepticus admissions. Acta Neurol Scand 1984; 70: 443-450 [PMID: 6516794]
45. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011; 343: d5422 [PMID: 21914766 DOI: 10.1136/bmj.d5422]
46. Jepsen P, Vilstrup H, Andersen PK, Sørensen HT. Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study. BMC Gastroenterol 2009; 9: 35 [PMID: 19450284 DOI: 10.1186/1471-230x-9-35]
47. Kalaitzakis E, Gunnarsdottir SA, Josefsson A, Björnsson E. Increased risk for malignant neoplasms among patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 168-174 [PMID: 21029788 DOI: 10.1016/j.cgh.2010.10.014]
48. Sørensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjær L, Linet M, Trichopoulos D, Vilstrup H, Olsen J. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28: 921-925 [PMID: 9755226]
49. Cabibbo G, Palmeri L, Palmeri S, Craxì A. Should cirrhosis change our attitude towards treating non-hepatic cancer? Liver Int 2012; 32: 21-27 [PMID: 22098398 DOI: 10.1111/ j.1478-3231.2011.02629.x]
50. Reuken PA, Stallmach A, Bruns T. Mortality after urinary tract infections in patients with advanced cirrhosis-Relevance of acute kidney injury and comorbidities. Liver Int 2013; 33: 220-230 [PMID: 23295053 DOI: 10.1111/liv.12029]
51. Gundling F, Seidl H, Schmidtler F, Löffler N, Strassen I, Wolf P, Pehl C, Schmidt T, Schepp W. Nonhepatic cancer in liver cirrhosis: a retrospective study of prevalence, complication rate after specific oncological treatment, follow-up and prognostic predictors of outcome in 354 patients with cirrhosis. Anticancer Res 2011; 31: 2931-2938 [PMID: 21868541]
52. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-1730 [PMID: 9848347]
53. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009; 338: b606 [PMID: 19502216 DOI: 10.1136/bmj.b606]